GlassScriptPhysician profile
Shreya Patel
NPI 1497214233
$2,881.10
in general payments reported to CMS, 2019-2025
19 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $576 · 2023: $1,318 · 2024: $861 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $325 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.07 |
| Travel and Lodging | $325.38 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.55 | 2022-2025 | |
| Lilly USA, LLC | $486.47 | 2022-2024 | Olumiant, Taltz |
| Janssen Biotech, INC. | $358.87 | 2023-2024 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $255.58 | 2022-2023 | |
| Ucb, INC. | $213.36 | 2023-2024 | Bimzelx, Cimzia |
| Amgen INC. | $134.82 | 2023-2024 | Otezla |
| Dermavant Sciences, INC. | $124.98 | 2024 | Vtama |
| Pfizer INC. | $87.33 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $80.57 | 2023-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $58.00 | 2024 | |
| Incyte Corporation | $40.93 | 2023-2024 | Opzelura |
| Genzyme Corporation | $34.11 | 2024 | |
| Galderma Laboratories, L.P. | $31.88 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $27.83 | 2024 | Zoryve |
| Organogenesis INC. | $24.56 | 2025 | Puraply Wound Matrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $17.43 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.62 | 2024 | Spevigo |
| Leo Pharma INC. | $16.48 | 2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $13.73 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shreya Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.